In contrast to CD40 expression, we found that both CD80 and CD86 expression on CD19+ B cells were significantly increased in patients with IgG4-RD, whereas their expression on CD19+ B cells was comparable between pSS and HC groups. Here, CD19 is linked to immunoglobulin G4-related sclerosing disease.